About Qlucore
Qlucore is a publicly listed company based in Lund (Sweden) founded in 2007. Bioinformatics software for omics data visualization and analysis is provided. Qlucore has raised $840 thousand across 5 funding rounds from investors including European Commission, European Union and Vinnova. Qlucore offers products and services including Qlucore Omics Explorer, Qlucore Insights, and Qlucore Diagnostics. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Discovery.
Company details
Qlucore was founded in 2007 in Lund, Sweden, within the bioinformatics sector. Software solutions are developed for the visualization and exploration of gene expression, protein arrays, miRNA, DNA methylation, and protein data. The primary tool, Qlucore Omics Explorer, facilitates synchronized plots, clustering operations, workflow customization, data subsetting, and varied coloring schemes. Operations center on enabling detailed analysis for research applications in life sciences.
- Headquarters Lund, Sweden
- Stage Public
- SectorsHealthcare
- Website qlucore.com
- Social LinkedIn X Facebook YouTube
- Legal Name Qlucore Ab
- Annual Revenue$726.56 K (USD)-34as on Apr 30, 2026
- Net Profit-$3.94 M (USD)-77.86as on Apr 30, 2026
- EBITDA-$3.01 M (USD)8.45as on Apr 30, 2026
- Total Equity Funding$840K (USD)
in 5 rounds
- Latest Funding Round$468.17K (USD), Grant
Jan 2023
- InvestorsEuropean Commission
& 3 more
Products & Services of Qlucore
Qlucore offers a comprehensive portfolio of products and services, including Qlucore Omics Explorer, Qlucore Insights, and Qlucore Diagnostics.
Visualization tool for multi-omics data in research.
Software for disease-specific sample analysis.
IVDR-certified test for leukemia diagnostics.
Apps and channels of Qlucore
its YouTube channel Qlucore has 615 subscribers and 30 videos.
Videos from Qlucore
The most watched videos on Qlucore's YouTube channel, Qlucore (615 subscribers). Click a video to play it here.
More on Qlucore.
Funding Insights of Qlucore
Qlucore has successfully raised a total of $840K across 5 strategic funding rounds. The most recent funding activity was a Grant round of $468.17 thousand completed in January 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $840,000
- Total Rounds 5
- Last Round Grant — $468,174
- First Round $840,000
(Oct 2012)
- Investors Count 4
All 5 funding rounds of Qlucore with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2023 | $468,174 | Grant | – | – | |
| Jan 2019 | $323,177 | Grant | – | – | |
| Sep 2013 | $801,360 | Grant | – | – | |
| Apr 2013 | Grant | – | – | ||
| Oct 2012 | $840,000 | Private Equity Round | – | – |
4 investors in total: 4 institutional.
Investors in Qlucore
Qlucore has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include European Commission, European Union and Vinnova.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm investing in early-stage companies in Sweden | gldinvest.com | Taby, Sweden | ||
Venture capital funding is provided to Swedish companies across sectors. | 2001 | vinnova.se | Stockholm, Sweden | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Institution of the European Union responsible for upholding the EU treaties | 1958 | ec.europa.eu | Brussels, Belgium |
Investor details for Qlucore
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Qlucore
16 people are tracked at Qlucore (9 in leadership, 7 in team).
| Name | Role | Group |
|---|---|---|
Cecilia Grotte | CFO | Leadership |
Erik Söderbäck | Head of Diagnostic Sales | Leadership |
Per Nordqvist | Head Of QA | Leadership |
Ulf Ahlfors | Head of R&D | Leadership |
Fredrik Hellborg | Sales Director Diagnostics | Leadership |
Anders Johansson | Sales Director | Leadership |
Carl-Johan Ivarsson | CEO | Leadership |
Matthew McGeough, MBA | Sales Director | Leadership |
Jan Nilsson | Sales Director | Leadership |
Mats Svensson | Software Engineer | Team |
Stefan Baka | Configuration Management And Test Specialist | Team |
Yana Khalina Stackpole | Sales and Support Manager | Team |
Caroline Brorsson | Bioinformatiker | Team |
Rasmus Henningsson | Software Engineer | Team |
Martin Hjelmstedt | System Developer | Team |
David Eklund | Team Lead | Team |
Complete people profiles for Qlucore
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Qlucore
Qlucore is a publicly listed company on the OMXSTO with ticker symbol QCORE in Sweden, operating in the Technology services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date05 Nov 2021
- Listed onOMXSTO: QCORE
- Listed entityQlucore AB
- Exchange sectorTechnology services
- ISINSE0016829824
- Share price0.36 SEK (+12.42% on the day) · 2026-10-13
- Market capitalisation15,529,981.00 SEK
- EPS (diluted, trailing year)-1.00 SEK
- Volume (last session)5,020
Financials of Qlucore
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 6.7M SEK | -36.5M SEK | -27.9M SEK |
| 2024 | 10.2M SEK | -20.5M SEK | -30.5M SEK |
| 2023 | 14.4M SEK | -15.7M SEK | -18.7M SEK |
| 2022 | 12.7M SEK | -15.9M SEK | -20.5M SEK |
| 2021 | 14.1M SEK | -11.7M SEK | -14.3M SEK |
Detailed financial statements for Qlucore
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Qlucore
4 dated milestones of Qlucore across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Qlucore is founded.
- Funding First funding round of $840K.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Grant, of $468K.
Web traffic of Qlucore
The website of Qlucore (qlucore.com) receives about 6.7K visits a month.
- Monthly visits6.7K
▼ 13.1% vs previous month
Websites whose visitors overlap most with Qlucore. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
bioinformaticshome.com | bioinformaticshome.com | 100% | #922,043 | – | |
lola.gwu.edu | lola.gwu.edu | 88% | – | ||
oligo.net | oligo.net | 88% | – | ||
| changbioscience.com | 88% | 2.7K | #6,300,532 | View details | |
rbuilder.sourceforge.net | rbuilder.sourceforge.net | 88% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 27 similar websites and full traffic analytics for Qlucore
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 27 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Qlucore
Complete news archive for Qlucore
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Qlucore
Qlucore was founded in 2007 and raised its 1st funding round 5 years after it was founded.
Qlucore is headquartered in Lund, Sweden.
Qlucore is a funded company, having raised a total of $840K across 5 funding rounds to date. The company's 1st funding round was a Private Equity Round of $840K, raised on Oct 2012.
Annual revenue of Qlucore is $726.56K as on Apr 30, 2026.
Qlucore was founded in 2007 in Lund, Sweden, within the bioinformatics sector. Software solutions are developed for the visualization and exploration of gene expression, protein arrays, miRNA, DNA methylation, and protein data. The primary tool, Qlucore Omics Explorer, facilitates synchronized plots, clustering operations, workflow customization, data subsetting, and varied coloring schemes. Operations center on enabling detailed analysis for research applications in life sciences.
Qlucore offers Qlucore Omics Explorer, Qlucore Insights, and Qlucore Diagnostics.
Yes, Qlucore is publicly traded on OMXSTO under the ticker symbol QCORE.
Qlucore has 4 investors. Key investors include European Commission, European Union, Vinnova, and GLD Invest.